NOX2 interacts with podocyte TRPC6 channels and contributes to their activation by diacylglycerol: Essential role of podocin in formation of this complex

American Journal of Physiology - Cell Physiology

Volumn 305, Issue 9, 2013, Pages

  Kim, Eun Young ^a   Anderson, Marc ^a   Wilson, Cory ^a   Hagmann, Henning ^b   Benzing, Thomas ^b   Dryer, Stuart E ^a,c  

^a University of Houston   (United States)

^b UNIVERSITY OF COLOGNE   (Germany)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Glomerular filtration; NADPH oxidase; Podocin; Podocyte; Slit diaphragm; TRPC6

Indexed keywords

1 OLEOYL 2 ACETYL SN GLYCEROL; APOCYNIN; CHOLESTEROL; DIACYLGLYCEROL; DIPHENYLIODONIUM SALT; METHYL BETA CYCLODEXTRIN; PODOCIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SHORT HAIRPIN RNA; TEMPOL; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL IMMORTALIZATION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; ENZYME ACTIVE SITE; IMMUNOPRECIPITATION; LIPID RAFT; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; STEADY STATE; SURFACE PROPERTY; WHOLE CELL;

GLOMERULAR FILTRATION; NADPH OXIDASE; PODOCIN; PODOCYTE; SLIT DIAPHRAGM; TRPC6;

ANIMALS; CELL LINE, TRANSFORMED; CHO CELLS; CRICETINAE; CRICETULUS; DIGLYCERIDES; GENE KNOCKDOWN TECHNIQUES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICE; NADPH OXIDASE; PODOCYTES; PROTEIN BINDING; TRPC CATION CHANNELS;

EID: 84886992162     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00191.2013     Document Type: Article

References (71)

1. Anderson M, Kim EY, Hagmann H, Benzing T, Dryer SE. Opposing effects of podocin on the gating of podocyte TRPC6 channels evoked by membrane stretch or diacylglycerol. Am J Physiol Cell Physiol 305: C276-C289, 2013.
2. Andrey F, Tsintsadze T, Volkova T, Lozovaya N, Krishtal O. Acid sensing ionic channels: modulation by redox reagents. Biochim Biophys Acta 1745: 1-6, 2005.
3. Asaba K, Tojo A, Onozato ML, Goto A, Quinn MT, Fujita T, Wilcox CS. Effects of NADPH oxidase inhibitor in diabetic nephropathy. Kidney Int 67: 1890-1898, 2005.
4. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87: 245-313, 2007.
5. Berg HC. Random Walks in Biology. Princeton, NJ: Princeton University Press, 1983.
6. Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A, Dahan K, Gubler MC, Niaudet P, Antignac C. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroidresistant nephrotic syndrome. Nat Genet 24: 349-354, 2000.
7. Brand J, Smith ES, Schwefel D, Lapatsina L, Poole K, Omerbašić D, Kozlenkov A, Behlke J, Lewin GR, Daumke O. A stomatin dimer modulates the activity of acid-sensing ion channels. EMBO J 31: 3635-3646, 2012.
8. Burnham DN, Uhlinger DJ, Lambeth JD. Diradylglycerol synergizes with an anionic amphiphile to activate superoxide generation and phosphorylation of p47phox in a cell-free system from human neutrophils. J Biol Chem 265: 17550-17559, 1990.
9. Chu XP, Close N, Saugstad JA, Xiong ZG. ASIC1a-specific modulation of acid-sensing ion channels in mouse cortical neurons by redox reagents. J Neurosci 26: 5329-5339, 2006.
10. Chung WS, Farley JM, Drummond HA. ASIC-like currents in freshly isolated cerebral artery smooth muscle cells are inhibited by endogenous oxidase activity. Cell Physiol Biochem 27: 129-138, 2011.
11. V2.1 into lipid rafts in cerebellum: implications for localization and function. J Neurosci 26: 8748-8757, 2006.
12. Faul C, Asanuma K, Yanagida-Asanuma E, Kim K, Mundel P. Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends Cell Biol 17: 428-437, 2007.
13. Fricke B, Stewart GW, Treharne KJ, Mehta A, Knöpfle G, Friedrichs N, Müller KM, von Düring M. Stomatin immunoreactivity in ciliated cells of the human airway epithelium. Anat Embryol (Berl) 207: 1-7, 2003.
14. Gallagher PG, Romana M, Lieman JH, Ward DC. cDNA structure, tissue-specific expression, and chromosomal localization of the murine band 7.2b gene. Blood 86: 359-365, 1995.
15. Gorudko IV, Mukhortava AV, Caraher B, Ren M, Cherenkevich SN, Kelly GM, Timoshenko AV. Lectin-induced activation of plasma membrane NADPH oxidase in cholesterol-depleted human neutrophils. Arch Biochem Biophys 516: 173-181, 2011.
16. 2 signaling axis in mice. J Clin Invest 117: 3445-3452, 2007.
17. Graham S, Ding M, Ding Y, Sours-Brothers S, Luchowski R, Gryczynski Z, Yorio T, Ma H, Ma R. Canonical transient receptor potential 6 (TRPC6), a redox-regulated cation channel. J Biol Chem 285: 23466-23476, 2010.
18. Guichard C, Pedruzzi E, Dewas C, Fay M, Pouzet C, Bens M, Vandewalle A, Ogier-Denis E, Gougerot-Pocidalo MA, Elbim C. Interleukin-8-induced priming of neutrophil oxidative burst requires sequential recruitment of NADPH oxidase components into lipid rafts. J Biol Chem 280: 37021-37032, 2005.
19. Heeringa SF, Möller CC, Du J, Yue L, Hinkes B, Chernin G, Vlangos CN, Hoyer PF, Reiser J, Hildebrandt F. A novel TRPC6 mutation that causes childhood FSGS. PLos One 4: e7771, 2009.
20. Heumüller S, Wind S, Barbosa-Sicard E, Schmidt HH, Busse R, Schröder K, Brandes RP. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 51: 211-217, 2008.
21. Hofmann T, Obukhov AG, Schaefer M, Harteneck C, Gudermann T, Schultz G. Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. Nature 397: 259-263, 1999.
22. Huber TB, Schermer B, Müller RU, Höhne M, Bartram M, Calixto A, Hagmann H, Reinhardt C, Koos F, Kunzelmann K, Shirokova E, Krautwurst D, Harteneck C, Simons M, Pavenstädt H, Kerjaschki D, Thiele C, Walz G, Chalfie M, Benzing T. Podocin and MEC-2 bind cholesterol to regulate the activity of associated ion channels. Proc Natl Acad Sci USA 103: 17079-17086, 2006.
23. Huber TB, Simons M, Hartleben B, Sernetz L, Schmidts M, Gundlach E, Saleem MA, Walz G, Benzing T. Molecular basis of the functional podocin-nephrin complex: mutations in the NPHS2 gene disrupt nephrin targeting to lipid raft microdomains. Hum Mol Genet 12: 3397-3405, 2003.
24. 2/ω-hydroxylase/20-HETE pathways. Circ Res 104: 1399-1409, 2009.
25. Jaquet V, Scapozza L, Clark RA, Krause KH, Lambeth JD. Smallmolecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets. Antioxid Redox Signal 11: 2535-2552, 2009.
26. Jiménez R, López-Sepúlveda R, Kadmiri M, Romero M, Vera R, Sánchez M, Vargas F, O'Valle F, Zarzuelo A, Dueñas M, Santos-Buelga C, Duarte J. Polyphenols restore endothelial function in DOCAsalt hypertension: role of endothelin-1 and NADPH oxidase. Free Radic Biol Med 43: 462-473, 2007.
27. Johnson DK, Schillinger KJ, Kwait DM, Hughes CV, McNamara EJ, Ishmael F, O'Donnell RW, Chang MM, Hogg MG, Dordick JS, Santhanam L, Ziegler LM, Holland JA. Inhibition of NADPH oxidase activation in endothelial cells by ortho-methoxy-substituted catechols. Endothelium 9: 191-203, 2002.
28. Kim EY, Anderson M, Dryer SE. Insulin increases surface expression of TRPC6 channels in podocytes: role of NADPH oxidases and reactive oxygen species. Am J Physiol Renal Physiol 302: F298-F307, 2012.
29. Kim EY, Anderson M, Dryer SE. Sustained activation of N-methyl-Daspartate receptors in podoctyes leads to oxidative stress, mobilization of transient receptor potential canonical 6 channels, nuclear factor of activated T cells activation, and apoptotic cell death. Mol Pharmacol 82: 728-737, 2012.
30. + channels: different effects in embryonic neurons and podocytes. Am J Physiol Cell Physiol 297: C1379-C1388, 2009.
31. + channel isoform and regulates its expression on the cell surface. Am J Physiol Renal Physiol 295: F235-F246, 2008.
32. Krall P, Canales CP, Kairath P, Carmona-Mora P, Molina J, Carpio JD, Ruiz P, Mezzano SA, Li J, Wei C, Reiser J, Young JI, Walz K. Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease. PLos One 5: e12859, 2010.
33. Kriz W, Shirato I, Nagata M, LeHir M, Lemley KV. The podocyte's response to stress: the enigma of foot process effacement. Am J Physiol Renal Physiol 304: F333-F347, 2013.
34. Lam GY, Fattouh R, Muise AM, Grinstein S, Higgins DE, Brumell JH. Listeriolysin O suppresses phospholipase C-mediated activation of the microbicidal NADPH oxidase to promote Listeria monocytogenes infection. Cell Host Microbe 10: 627-634, 2011.
35. Lavin PJ, Winn MP. TORCing up the importance of calcium signaling. J Am Soc Nephrol 22: 1391-1393, 2011.
36. Liu BC, Song X, Lu XY, Li DT, Eaton DC, Shen BZ, Li XQ, Ma HP. High glucose induces podocyte apoptosis by stimulating TRPC6 via elevation of reactive oxygen species. Biochim Biophys Acta 1833: 1434-1442, 2013.
37. Maxfield FR, Wüstner D. Analysis of cholesterol trafficking with fluorescent probes. Methods Cell Biol 108: 367-393, 2012.
38. Miki H, Funato Y. Regulation of intracellular signalling through cysteine oxidation by reactive oxygen species. J Biochem 151: 255-261, 2012.
39. Möller CC, Wei C, Altintas MM, Li J, Greka A, Ohse T, Pippin JW, Rastaldi MP, Wawersik S, Schiavi S, Henger A, Kretzler M, Shankland SJ, Reiser J. Induction of TRPC6 channel in acquired forms of proteinuric kidney disease. J Am Soc Nephrol 18: 29-36, 2007.
40. Mollet G, Ratelade J, Boyer O, Muda AO, Morisset L, Lavin TA, Kitzis D, Dallman MJ, Bugeon L, Hubner N, Gubler MC, Antignac C, Esquivel EL. Podocin inactivation in mature kidneys causes focal segmental glomerulosclerosis and nephrotic syndrome. J Am Soc Nephrol 20: 2181-2189, 2009.
41. Montesano R. Inhomogeneous distribution of filipin-sterol complexes in smooth muscle cell plasma membrane. Nature 280: 328-329, 1979.
42. Morrow IC, Parton RG. Flotillins and the PHB domain protein family: rafts, worms and anaesthetics. Traffic 6: 725-740, 2005.
43. Nijenhuis T, Sloan AJ, Hoenderop JG, Flesche J, van Goor H, Kistler AD, Bakker M, Bindels RJ, de Boer RA, Möller CC, Hamming I, Navis G, Wetzels JF, Berden JH, Reiser J, Faul C, van der Vlag J. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway. Am J Pathol 179: 1719-1732, 2011.
44. Orci L, Singh A, Amherdt M, Brown D, Perrelet A. Microheterogeneity of protein and sterol content in kidney podocyte membrane. Nature 293: 646-647, 1981.
45. Park JW, Babior BM. The translocation of respiratory burst oxidase components from cytosol to plasma membrane is regulated by guanine nucleotides and diacylglycerol. J Biol Chem 267: 19901-19906, 1992.
46. Pavenstädt H, Kriz W, Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev 83: 253-307, 2003.
47. Pendyala S, Usatyuk PV, Gorshkova IA, Garcia JG, Natarajan V. Regulation of NADPH oxidase in vascular endothelium: the role of phospholipases, protein kinases, and cytoskeletal proteins. Antioxid Redox Signal 11: 841-860, 2009.
48. Price MP, Thompson RJ, Eshcol JO, Wemmie JA, Benson CJ. Stomatin modulates gating of acid-sensing ion channels. J Biol Chem 279: 53886-53891, 2004.
49. Qualliotine-Mann D, Agwu DE, Ellenburg MD, McCall CE, McPhail LC. Phosphatidic acid and diacylglycerol synergize in a cell-free system for activation of NADPH oxidase from human neutrophils. J Biol Chem 268: 23843-23849, 1993.
50. Reiser J, Polu KR, Möller CC, Kenlan P, Altintas MM, Wei C, Faul C, Herbert S, Villegas I, Avila-Casado C, McGee M, Sugimoto H, Brown D, Kalluri R, Mundel P, Smith PL, Clapham DE, Pollak MR. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet 37: 739-744, 2005.
51. Roselli S, Gribouval O, Boute N, Sich M, Benessy F, Attié T, Gubler MC, Antignac C. Podocin localizes in the kidney to the slit diaphragm area. Am J Pathol 160: 131-139, 2002.
52. Rugale C, Delbosc S, Mimran A, Jover B. Simvastatin reverses target organ damage and oxidative stress in angiotensin II hypertension: comparison with apocynin, tempol, and hydralazine. J Cardiovasc Pharmacol 50: 293-298, 2007.
53. Rungaldier S, Oberwagner W, Salzer U, Csaszar E, Prohaska R. Stomatin interacts with GLUT1/SLC2A1, band 3/SLC4A1, and aquaporin-1 in human erythrocyte membrane domains. Biochim Biophys Acta 1828: 956-966, 2013.
54. Schlöndorff J, Del Camino D, Carrasquillo R, Lacey V, Pollak MR. TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFAT-dependent transcription. Am J Physiol Cell Physiol 296: C558-C569, 2009.
55. Schwarz K, Simons M, Reiser J, Saleem MA, Faul C, Kriz W, Shaw AS, Holzman LB, Mundel P. Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest 108: 1621-1629, 2001.
56. Shao D, Segal AW, Dekker LV. Lipid rafts determine efficiency of NADPH oxidase activation in neutrophils. FEBS Lett 550: 101-106, 2003.
57. Shirato I. Podocyte process effacement in vivo. Microsc Res Tech 57: 241-246, 2002.
58. Stefanska J, Pawliczak R. Apocynin: molecular aptitudes. Mediators Inflamm 2008: 106507, 2008.
59. Storch U, Mederos y Schnitzler M., Gudermann T. G protein-mediated stretch reception. Am J Physiol Heart Circ Physiol 302: H1241-H1249, 2012.
60. Thallas-Bonke V, Coughlan MT, Bach LA, Cooper ME, Forbes JM. Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy. Am J Nephrol 32: 73-82, 2010.
61. Tian N, Moore RS, Phillips WE, Lin L, Braddy S, Pryor JS, Stockstill RL, Hughson MD, Manning RD Jr. NADPH oxidase contributes to renal damage and dysfunction in Dahl salt-sensitive hypertension. Am J Physiol Regul Integr Comp Physiol 295: R1858-R1865, 2008.
62. Tyagi SR, Neckelmann N, Uhlinger DJ, Burnham DN, Lambeth JD. Cell-free translocation of recombinant p47-phox, a component of the neutrophil NADPH oxidase: effects of guanosine 5=-O-(3-thiotriphosphate), diacylglycerol, and an anionic amphiphile. Biochemistry 31: 2765-2774, 1992.
63. Usatyuk PV, Gorshkova IA, He D, Zhao Y, Kalari SK, Garcia JG, Natarajan V. Phospholipase D-mediated activation of IQGAP1 through Rac1 regulates hyperoxia-induced p47phox translocation and reactive oxygen species generation in lung endothelial cells. J Biol Chem 284: 15339-15352, 2009.
64. Vilhardt F, van Deurs B. The phagocyte NADPH oxidase depends on cholesterol-enriched membrane microdomains for assembly. EMBO J 23: 739-748, 2004.
65. Wang Z, Wei X, Zhang Y, Ma X, Li B, Zhang S, Du P, Zhang X, Yi F. NADPH oxidase-derived ROS contributes to upregulation of TRPC6 expression in puromycin aminonucleoside-induced podocyte injury. Cell Physiol Biochem 24: 619-626, 2009.
66. Wilcox CS. Effects of tempol and redox-cycling nitroxides in models of oxidative stress. Pharmacol Ther 126: 119-145, 2010.
67. Wind S, Beuerlein K, Eucker T, Müller H, Scheurer P, Armitage ME, Ho H, Schmidt HH, Wingler K. Comparative pharmacology of chemically distinct NADPH oxidase inhibitors. Br J Pharmacol 161: 885-898, 2010.
68. Winn MP, Conlon PJ, Lynn KL, Farrington MK, Creazzo T, Hawkins AF, Daskalakis N, Kwan SY, Ebersviller S, Burchette JL, Pericak-Vance MA, Howell DN, Vance JM, Rosenberg PB. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 308: 1801-1804, 2005.
69. Yadav A, Vallabu S, Arora S, Tandon P, Slahan D, Teichberg S, Singhal PC. ANG II promotes autophagy in podocytes. Am J Physiol Cell Physiol 299: C488-C496, 2010.
70. Zhan H, Moore CS, Chen B, Zhou X, Ma XM, Ijichi K, Bennett MV, Li XJ, Crocker SJ, Wang ZW. Stomatin inhibits pannexin-1-mediated whole-cell currents by interacting with its carboxyl terminal. PLos One 7: e39489, 2012.
71. Zidovetzki R, Levitan I. Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies. Biochim Biophys Acta 1768: 1311-1324, 2007.